Fmr LLC trimmed its position in MAXIMUS, Inc. (NYSE:MMS) by 40.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 923,272 shares of the health services provider’s stock after selling 620,525 shares during the quarter. Fmr LLC’s holdings in MAXIMUS were worth $60,068,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Bruderman Asset Management LLC purchased a new position in MAXIMUS during the second quarter valued at approximately $119,000. Fort L.P. purchased a new position in MAXIMUS during the second quarter valued at approximately $120,000. Advisors Asset Management Inc. raised its position in MAXIMUS by 132.3% during the second quarter. Advisors Asset Management Inc. now owns 3,807 shares of the health services provider’s stock valued at $461,000 after acquiring an additional 2,168 shares in the last quarter. Engineers Gate Manager LP purchased a new position in MAXIMUS during the third quarter valued at approximately $254,000. Finally, Tower Research Capital LLC TRC raised its position in MAXIMUS by 72.4% during the second quarter. Tower Research Capital LLC TRC now owns 4,061 shares of the health services provider’s stock valued at $253,000 after acquiring an additional 1,706 shares in the last quarter. Hedge funds and other institutional investors own 93.26% of the company’s stock.

MAXIMUS stock opened at $67.57 on Tuesday. The company has a market capitalization of $4.45 billion, a PE ratio of 19.87, a price-to-earnings-growth ratio of 1.90 and a beta of 1.02. MAXIMUS, Inc. has a 12 month low of $60.00 and a 12 month high of $72.71.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Tuesday, November 20th. The health services provider reported $0.71 EPS for the quarter, missing the Zacks’ consensus estimate of $0.72 by ($0.01). The business had revenue of $558.50 million during the quarter, compared to analysts’ expectations of $587.58 million. MAXIMUS had a net margin of 9.23% and a return on equity of 20.23%. The firm’s quarterly revenue was down 10.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.81 earnings per share. As a group, sell-side analysts anticipate that MAXIMUS, Inc. will post 3.66 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 30th. Stockholders of record on Thursday, November 15th were given a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, November 14th. This is a boost from MAXIMUS’s previous quarterly dividend of $0.05. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.48%. MAXIMUS’s payout ratio is 29.41%.

A number of analysts have recently commented on the company. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a research report on Friday, November 23rd. ValuEngine upgraded MAXIMUS from a “hold” rating to a “buy” rating in a research report on Friday, November 30th. Finally, Canaccord Genuity boosted their price objective on MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research report on Wednesday, October 10th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. MAXIMUS currently has a consensus rating of “Buy” and a consensus price target of $72.00.

In other news, Vice Chairman Richard A. Montoni sold 30,000 shares of MAXIMUS stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $72.03, for a total value of $2,160,900.00. Following the sale, the insider now directly owns 429,874 shares of the company’s stock, valued at $30,963,824.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Vice Chairman Richard A. Montoni sold 44,002 shares of MAXIMUS stock in a transaction that occurred on Thursday, September 20th. The stock was sold at an average price of $64.99, for a total value of $2,859,689.98. Following the completion of the sale, the insider now directly owns 493,476 shares in the company, valued at $32,071,005.24. The disclosure for this sale can be found here. Insiders sold 118,124 shares of company stock valued at $8,018,300 over the last 90 days. Company insiders own 2.48% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US & international copyright & trademark law. The legal version of this piece of content can be read at https://www.dailypolitical.com/2018/12/18/maximus-inc-mms-shares-sold-by-fmr-llc.html.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Further Reading: What are no-load funds?

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.